Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALB | P02768 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TUBB | P07437 | 1/20 | 0.31 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.31 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.31 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.31 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.31 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.31 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3611465 | 1.00 | KDM4E (0.42) | KDM4EADRA2BMAPK1ALDH1A1HPGD | |
| SCHEMBL13502976 | 0.89 | MEN1 (0.39) | KDM4EMAPK1ALDH1A1HPGDKMT2A | |
| SCHEMBL3609083 | 0.88 | KDM4E (0.39) | KDM4EADRA2BMAPK1ALDH1A1HPGD | |
| SCHEMBL3609081 | 0.88 | KDM4E (0.39) | KDM4EADRA2BMAPK1ALDH1A1HPGD | |
| SCHEMBL25379757 | 0.81 | CES2 (0.31) | — | |
| SCHEMBL9746643 | 0.81 | CES2 (0.31) | — | |
| SCHEMBL9748463 | 0.81 | CES2 (0.31) | — | |
| SCHEMBL10515038 | 0.79 | — | — | |
| SCHEMBL10516094 | 0.79 | — | — | |
| SCHEMBL9565709 | 0.77 | KDM4E (0.44) | KDM4EADRA2BMAPK1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029938-A1 | PROCESS FOR THE PREPARATION OF AN ANTIBACTERIAL QUINOLONE COMPOUND | FARMAPROJECTS, S. A. (ES) | 2010-02-04 | — | — | US | disclosed |
| WO-2008077643-A1 | PROCESS FOR THE PREPARATION OF AN ANTIBACTERIAL QUINOLONE COMPOUND | FARMAPROJECTS, S.A. (ES) | 2008-07-03 | — | — | WO | disclosed |
| EP-1939206-A1 | Process for the preparation of an antibacterial quinolone compound | Farmaprojects, S.A. (ES) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029938-A1 | PROCESS FOR THE PREPARATION OF AN ANTIBACTERIAL QUINOLONE COMPOUND | CYP3A4, CYP4B1, CYP4F11 | KDM4E 998/4885ADRA2B 1033/4885MAPK1 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.